Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study

Download

Authors: Robert M. Geiger, Carlos Serna III, Bhavya Bhardwaj, Tromondae K. Feaster,  and Ksenia Blinova

Frontiers in Drug Discovery, 09 November 2025

Related Resources
Nonclinical human neural new approach methodologies (NAMs): Electrophysiological assessment of opioid agonist and antagonist combination
New approach methodologies (NAM) to characterize neurotoxic chemicals for use in risk assessment: case study of four neurotoxic pesticides
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform for Modeling Arrhythmias

Related Products

Axion BioSystems Maestro Pro MEA system

Maestro Pro

Axion BioSystems Cardiac software Module for MEA experiments

Cardiac Module

Axion BioSystems CytoView MEA plate

CytoView MEA Plate